Company Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye.
The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
It serves health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as ophthalmologists.
The company sells its products directly through its sales representatives in Japan, the United States, Germany, Spain, Singapore, Canada, and the United Kingdom, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.
STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
| Country | United States |
| Founded | 1982 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 921 |
| CEO | Stephen Farrell |
Contact Details
Address: 25510 Commercentre Drive Lake Forest, California 92630 United States | |
| Phone | 626 303 7902 |
| Website | staar.com |
Stock Details
| Ticker Symbol | STAA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | February - January |
| Reporting Currency | USD |
| CIK Code | 0000718937 |
| CUSIP Number | 852312305 |
| ISIN Number | US8523123052 |
| Employer ID | 95-3797439 |
| SIC Code | 3851 |
Key Executives
| Name | Position |
|---|---|
| Warren Foust | Interim Co-Chief Executive Officer, President and Chief Operating Officer |
| Deborah J. Andrews | Interim Co-Chief Executive Officer and Chief Financial Officer |
| Dr. Magda Michna Ph.D. | Chief Development Officer |
| Connie Johnson | Director of Investor Relations |
| Kathleen Determann J.D. | Vice President, Deputy General Counsel and Chief Compliance and Privacy Officer |
| Dr. Scott D. Barnes M.D. | Chief Medical Officer |
| Filip De Keersmaecker | Senior Vice President of Global E2E Supply Chain |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 24, 2026 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 22, 2026 | 8-K | Current Report |
| Jun 9, 2026 | 8-K | Current Report |
| May 13, 2026 | 10-Q | Quarterly Report |
| May 13, 2026 | 8-K | Current Report |
| May 12, 2026 | SCHEDULE 13G | Filing |
| May 4, 2026 | ARS | Filing |
| May 4, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| May 4, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 24, 2026 | SCHEDULE 13G/A | Filing |